AsghariHanjani Nazanin, Vafa Mohammadreza
Department of Nutrition, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.
Pediatric Growth and Development Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran.
Med J Islam Repub Iran. 2019 Jun 17;33:56. doi: 10.34171/mjiri.33.56. eCollection 2019.
Insulin-like growth factor1 (IGF1) is a polypeptide that structurally is similar to human pro-insulin, one of the factors that is altered in obesity and many related diseases, hence a large body of research devoted to evaluate it. In this mini-review, we briefly explain the role of IGF1 in different conditions, including obesity, cardiovascular disease, and cancer through the results of review and original articles in both animal and human studies. The short-term metabolic effect of IGF-1 is insulin-like, and its long-term effect is growth factor-like. IGF1 has different roles in the initiation and progression of different diseases, because in some cases, the anti-apoptotic effect, can help cell survival while in others, it may lead to cancer or increment of adipocytes. It is highly recommended to consider the different impacts of IGF1 in health and diseases prevention in future studies and interventions.
胰岛素样生长因子1(IGF1)是一种多肽,其结构与人类胰岛素原相似,是肥胖及许多相关疾病中发生改变的因素之一,因此有大量研究致力于对其进行评估。在本综述中,我们通过动物和人体研究的综述及原创文章结果,简要阐述IGF1在不同情况下的作用,包括肥胖、心血管疾病和癌症。IGF-1的短期代谢作用类似胰岛素,其长期作用则类似生长因子。IGF1在不同疾病的发生和发展中具有不同作用,因为在某些情况下,其抗凋亡作用可帮助细胞存活,而在其他情况下,它可能导致癌症或脂肪细胞增加。强烈建议在未来的研究和干预中考虑IGF1对健康和疾病预防的不同影响。